Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 4382-4388, December 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janeway, C. M.
Right arrow Articles by Cha, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janeway, C. M.
Right arrow Articles by Cha, S.

Effects of 6-Azauridine on Nucleotides, Orotic Acid, and Orotidine in L5178Y Mouse Lymphoma Cells in Vitro1

Claude M. Janeway and Sungman Cha

Division of Biology and Medicine, Brown University, Providence, Rhode Island 02912

Murine lymphoma L5178Y cells in culture were exposed to 5 µM 6-azauridine (6-aza-UR) for up to 8 hr. The nucleotides in the acid-soluble extracts were determined by high-pressure liquid chromatography. The concentrations of uracil and cytosine nucleotides decreased rapidly in the treated cells. Adenosine 5'-triphosphate and adenosine 5'-diphosphate increased steadily, whereas guanosine 5'-diphosphate decreased for a few hr before returning to the normal level. Orotic acid and orotidine, but no detectable amount of orotidine monophosphate (OMP), accumulated in treated cells. In homogenates of the cells harvested from ascitic fluids of mice, the presence of a membrane-bound phosphatase with activity for OMP was demonstrated, which may be responsible for the lack of OMP accumulation. When incubated with the homogenate, [7-14C]OMP was converted to [7-14C]orotidine in the absence of inorganic phosphate, but it was converted to [7-14C]orotic acid in the presence of phosphate, suggesting the occurrence of an orotidine phosphorylase. The increase in adenosine 5'-triphosphate levels and the rapid decrease in the pyrimidine nucleotides observed after treatment with 6-aza-UR may be responsible for the observation (Brenckman et al., Biochem. Biophys. Res. Commun., 52: 1368–1373, 1973) that 6-aza-UR potentiates the activity of 1-ß-D-arabinofuranosylcytosine only when 6-aza-UR is added prior to 1-ß-D-arabinofuranosylcytosine.

1 Supported by USPHS Grants CA 12531 and CA 13943.

Received 6/22/77. Accepted 8/31/77.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.